Neurol. praxi. 2023;24(2):146-150 | DOI: 10.36290/neu.2023.002

Left­‑sided hemicrania - not a migraine!

MUDr. Petr Hollý1, 2, MUDr. Ivana Slámová3, MUDr. Svatopluk Ostrý, Ph.D.2, 4
1 Neurologická klinika a centrum klinických neurověd 1. lékařské fakulty Univerzity Karlovy a Všeobecné fakultní nemocnice v Praze
2 Neurologické oddělení, Nemocnice České Budějovice, a. s.
3 Infekční oddělení, Nemocnice České Budějovice, a. s.
4 Neurochirurgická a Neuroonkologická klinika, 1. lékařská fakulta, Univerzita Karlova v Praze a Ústřední vojenská nemocnice - Vojenská fakultní nemocnice, Praha

Headache is a very common symptom that a patient presents with in the acute outpatient clinic. Repeated migraine-like headache can be misleading and lead to partial downplaying of the difficulty, but it is of course appropriate to perform an imaging examination if this has not already been done. We present here an example of a young patient who visited our outpatient clinic in similar circumstances with very surprising findings on neuroimaging, her diagnosis, treatment, and evolution over time. We demonstrate here the importance of assessing the sensitivity of individual tests and, even if the diagnostic criteria were not met, the high suspicion of a disease that is very rare in our country.

Keywords: cephalea, neurocysticercosis.

Received: October 1, 2022; Revised: November 28, 2022; Accepted: January 9, 2023; Prepublished online: January 9, 2023; Published: April 21, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hollý P, Slámová I, Ostrý S. Left­‑sided hemicrania - not a migraine! Neurol. praxi. 2023;24(2):146-150. doi: 10.36290/neu.2023.002.
Download citation

References

  1. Carpio A, Campoverde A, Romo ML, et al. Validity of a PCR assay in CSF for the diagnosis of neurocysticercosis. Neurol Neuroimmunol Neuroinflamm. 2017;4:e324. Go to original source... Go to PubMed...
  2. Del Brutto OH, Campos X. Massive neurocysticercosis: encephalitic versus non­‑encephalitic. Am J Trop Med Hyg. 2012;87:381. Go to original source... Go to PubMed...
  3. Del Brutto OH, Nash TE, White AC, et al. Revised diagnostic criteria for neurocysticercosis. J Neurol Sci. 2017;372: 202-210. Go to original source... Go to PubMed...
  4. Garcia HH, Nash TE, Del Brutto OH. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol. 2014;13:1202-15. Go to original source... Go to PubMed...
  5. Glor SB, Edelhofer R, Grimm F, et al. Evaluation of a commercial ELISA kit for detection of antibodies against Toxoplasma gondii in serum, plasma and meat juice from experimentally and naturally infected sheep. Parasit Vectors. 2013;6:85. Go to original source... Go to PubMed...
  6. Guzman C, Garcia HH, P. Cysticercosis Working Group in 2021. Current Diagnostic Criteria for Neurocysticercosis. Res Rep Trop Med. 2021;12:197-203. Go to original source... Go to PubMed...
  7. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1-211. Go to original source...
  8. Kurča E. Neurologické prejavy vybraných opomínaných tropických ochorení. Neurol. praxi. 2019;20(2):98-101. Go to original source...
  9. Smrčka M, Šprláková A, Smrčka V, et al. Problematika indikace operační léčby u intramedulárních lézí. Cesk Slov Neurol N. 2010;73/106(4):393-397.
  10. Rodriguez S, Wilkins SP, Dorny P. Immunological and molecular diagnosis of cysticercosis. Pathog Glob Health. 2012;106:286-98. Go to original source... Go to PubMed...
  11. Singh G, Burneo JG, Sander JW. From seizures to epilepsy and its substrates: neurocysticercosis. Epilepsia. 2013;54:783-92. Go to original source... Go to PubMed...
  12. Trevisan C, Sotiraki S, Laranjo­‑Gonzalez M, et al. Epidemiology of taeniosis/cysticercosis in Europe, a systematic review: eastern Europe. Parasit Vectors. 2018;11:569. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.